Elevation in interleukin 13 levels in patients diagnosed with systemic inflammatory response syndrome

[1]  R. Mortimer,et al.  Evaluation of Random Plasma Cortisol and the Low Dose Corticotropin Test as Indicators of Adrenal Secretory Capacity in Critically Ill Patients: A Prospective Study , 2005, Anaesthesia and intensive care.

[2]  J. Pugin,et al.  Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines , 2004, Intensive Care Medicine.

[3]  P. Guillou,et al.  Interleukin 13 and inflammatory markers in human sepsis , 2004, The British journal of surgery.

[4]  S. Hirai.  Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. , 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[5]  T. Wynn.  IL-13 effector functions. , 2003, Annual review of immunology.

[6]  E. Roth,et al.  Is monocyte HLA-DR expression predictive for clinical outcome in sepsis? , 2003, Intensive Care Medicine.

[7]  F. Santolaria,et al.  Prognostic value of cytokines in SIRS general medical patients. , 2001, Cytokine.

[8]  N. Petrovsky.  Towards a unified model of neuroendocrine–immune interaction , 2001, Immunology and cell biology.

[9]  O. Kemmotsu,et al.  Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome , 2001, Intensive Care Medicine.

[10]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[11]  R. Strieter,et al.  Expression and Contribution of Endogenous IL-13 in an Experimental Model of Sepsis1 , 2000, The Journal of Immunology.

[12]  M Tan,et al.  A Bayesian hierarchical model for multi-level repeated ordinal data: analysis of oral practice examinations in a large anaesthesiology training programme. , 1999, Statistics in medicine.

[13]  L C Harrison,et al.  Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. , 1998, Cytokine.

[14]  R. Westendorp,et al.  Anti-inflammatory cytokine profile and mortality in febrile patients , 1998, The Lancet.

[15]  U. Losert,et al.  Gene transfer with IL‐4 and IL‐13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence , 1998, European journal of immunology.

[16]  R. Bone,et al.  Immunologic Dissonance: A Continuing Evolution in Our Understanding of the Systemic Inflammatory Response Syndrome (SIRS) and the Multiple Organ Dysfunction Syndrome (MODS) , 1996, Annals of Internal Medicine.

[17]  J. Christman,et al.  Sepsis and cytokines: current status. , 1996, British journal of anaesthesia.

[18]  W. Busse,et al.  Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. , 1995, American journal of respiratory and critical care medicine.

[19]  I. Vermes,et al.  Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. , 1995, The Journal of clinical endocrinology and metabolism.

[20]  L. Elfman,et al.  Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.

[21]  L. Casey.  Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. , 1993, The Annals of thoracic surgery.

[22]  R. Bone,et al.  Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) , 1992, JAMA.

[23]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[24]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[25]  Y. Hishikawa,et al.  Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin, and cortisol in normal men. , 1980, The Journal of clinical endocrinology and metabolism.

[26]  M. Dardenne,et al.  The neuroendocrine-immune axis , 2004, Springer Seminars in Immunopathology.

[27]  H. Volk,et al.  Immunomodulatory therapies in sepsis , 2000, Intensive Care Medicine.

[28]  G. Van den Berghe,et al.  Novel insights into the neuroendocrinology of critical illness. , 2000, European journal of endocrinology.

[29]  C. Cantamessa,et al.  Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome. , 2000, Mediators of inflammation.

[30]  R. Bone,et al.  T-cell reactivity and its predictive role in immunosuppression after burns. , 1999, Critical care medicine.

[31]  J Licinio,et al.  Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. , 1998, The Journal of clinical endocrinology and metabolism.

[32]  R. Bone,et al.  To SIRS with love. , 1998, Critical care medicine.

[33]  Dellinger Rp,et al.  To SIRS with love. , 1998 .

[34]  M. Kaghad,et al.  Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. , 1993, Nature.

[35]  J. Blalock.  A molecular basis for bidirectional communication between the immune and neuroendocrine systems. , 1989, Physiological reviews.